Enhanced recovery after surgery (ERAS) for vascular surgery: an evidence map and scoping review

Systematic Reviews

Letter

Karen Woo¹  Julia Rollison²  Sangita Baxi³  Susanne Hempel⁴  Aneesa Motala⁴  Eric A. Apaydin⁵ 

[1]Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA

[2]RAND Health Care, RAND Corporation, Arlington, VA, USA

[3]RAND Health Care, RAND Corporation, Santa Monica, CA, USA

[4]Southern California Evidence Review Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

[5]RAND Health Care, RAND Corporation, Santa Monica, CA, USA

[6]Southern California Evidence Review Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

[7]RAND Health Care, RAND Corporation, Santa Monica, CA, USA

[8]Center for the Study of Healthcare Innovation, Implementation, and Policy, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA

关键词: Enhanced recovery;    Surgery;    Vascular;    Evidence map;   

DOI  :  10.1186/s13643-023-02324-z

 received in 2023-06-28, accepted in 2023-08-15,  发布年份 2023

来源: Springer

【 摘 要 】

BackgroundEnhanced recovery after surgery (ERAS) interventions aim to improve patient outcomes. Vascular surgery patients have unique requirements and it is unclear which ERAS interventions are supported by an evidence base.MethodsWe conducted a scoping review to identify ERAS randomized controlled trials (RCTs) published in the biomedical or nursing literature. We assessed interventions for applicability to vascular surgery and differentiated interventions given at preadmission, preoperative, intraoperative, and postoperative surgery stages. We documented the research in an evidence map.ResultsWe identified 76 relevant RCTs. Interventions were mostly administered in preoperative (23 RCTs; 30%) or intraoperative surgery stages (35 RCTs; 46%). The majority of studies reported mortality outcomes (44 RCTs; 58%), but hospital (27 RCTs; 35%) and intensive care unit (9 RCTs; 12%) length of stay outcomes were less consistently described.ConclusionThe ERAS evidence base is growing but contains gaps. Research on preadmission interventions and more consistent reporting of key outcomes is needed.

【 授权许可】

CC BY   
© BioMed Central Ltd., part of Springer Nature 2023

【 图 表 】

12888_2023_5172_Article_IEq42.gif

41408_2023_919_Article_IEq12.gif